Persist AI

Persist AI is an AI-driven robotics platform revolutionizing pharmaceutical development by accelerating drug formulation development. The platform uses AI models and robotic systems to predict, build, and test drug formulations, reducing development time from years to months. Persist AI's Cloud Lab allows pharmaceutical companies to remotely build and test formulations.

Funding Round: Series A

Funding Amount: $12M

Date: 19-May-2025

Investors: Spero Ventures, MBX Capital, Shimadzu Future Innovation Fund managed by Global Brain Corporation, Eli Lilly & Company, SignalFire, Ford Street Capital, Purdue Ventures, Good AI Capital, Cartography Capital, Asymmetry Ventures, 2048 Ventures, Innospark, YCombinator

Markets: Pharmaceuticals, AI, Robotics

HQ: West Sacramento, California, United States

Founded: 2022

Website: https://www.persist-ai.com

LinkedIn: https://www.linkedin.com/company/persist-ai

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/persist-ai

Pitchbook: https://pitchbook.com/profiles/company/513338-68